Sofia Agelaki is an Associate Professor of Medical Oncology at the Medical School, University of Crete, and Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece. She received her PhD in 2003 and during 2003-2004 she worked as a Post-Doctoral fellow in the Laboratory of Thoracic and Head and Neck Medical Oncology, at the University of Texas, MD Anderson Cancer Center, Houston, TX. She is involved in the conduct of a multitude of international and national multicenter clinical trials mainly in lung and breast cancer as principal investigator and sub-investigator. She has actively participated in several EU funded projects and National research projects. She has co-authored more than 130 articles in peer reviewed journals (h-index 33), and presented more than 200 abstracts in international meetings. She has served as the chief editor of the Journal of the Hellenic Society of Clinical Oncology, HESMO) (2014-2018) and as a reviewer in many international journals. She has significantly contributed in the evaluation of liquid biopsy as a tool to improve patient stratification and to identify novel treatment targets and mechanisms of resistance in patients with cancer.
Current research interests include:
- Investigation of the role of circulating tumor cells and circulating nucleic acids as a tool for treatment guidance and real time monitoring of disease in patients with lung and breast cancer
- Identification of liquid based biomarkers of response to immunotherapy
- Role of cancer cachexia in immunotherapy response and tolerance in lung cancer patients